| Schedule of derivative liabilities at fair value |
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | | | | | | | | | Fair value of convertible notes derivative liability and equity securities – March 31, 2022 | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | | | | | | | | | Fair value of convertible notes derivative liability and equity securities – March 31, 2021 | | $ | 547,010 | | | $ | - | | | $ | - | | | $ | 547,010 | |
|
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | | | | | | | | | Fair value of convertible notes derivative liability and equity securities – December 31, 2021 | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
| | Level 1 | | | Level 2 | | | Level 3 | | | Total | | | | | | | | | | | | | | | Fair value of convertible notes derivative liability and equity securities – December 31, 2020 | | $ | 588,637 | | | $ | - | | | $ | - | | | $ | 588,637 | |
|
| Schedule of antidilutive securities excluded from computation of earnings per share |
| | Three Months Ended | | | Three Months Ended | | | | March 31, | | | March 31, | | | | 2022 | | | 2021 | | | | | | | | | Series A Preferred Stock | | | 1,405,972,450 | | | | 1,475,000,000 | | Series B Preferred Stock | | | 314,754 | | | | 2,675,410 | | Series C Preferred Stock | | | 747,540 | | | | 747,540 | | Series D Preferred Stock | | | 1,395,349 | | | | 1,395,349 | | Convertible notes | | | 20,000 | | | | 20,000 | | Warrants | | | - | | | | 10,000,000 | | Potentially dilutive securities | | | 1,408,450,093 | | | | 1,489,838,299 | |
|
| | Year Ended | | | Year Ended | | | | December 31, | | | December 31, | | | | 2021 | | | 2020 | | | | | | | | | Series A Preferred Stock | | | 1,408,825,375 | | | | 1,500,000,000 | | Series B Preferred Stock | | | 314,754 | | | | 2,675,410 | | Series C Preferred Stock | | | 747,540 | | | | | | Series D Preferred Stock | | | 1,395,349 | | | | | | Convertible notes | | | 20,000 | | | | 20,000 | | Warrants | | | - | | | | 10,000,000 | | Potentially dilutive securities | | | 1,411,303,018 | | | | 1,512,695,410 | |
|
| Schedule of Changes in the fair value of the Company's Level 3 financial liabilities |
|
| | Derivative Liability | | Balance, December 31, 2019 | | | 2,813,150 | | Additions recognized as debt discount | | | 984,801 | | Derivative liability settlements | | | (3,053,213 | ) | Mark-to-market at December 31, 2020 | | | (744,738 | ) | Balance, December 31, 2020 | | $ | - | | | | | | | Net income for the year included in earnings relating to the liabilities held at December 31, 2020 | | $ | 744,738 | |
|